- Home
- CTRN vs RCKT Comparison
CTRN vs RCKT Comparison
Compare CTRN & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTRN
- RCKT
- Stock Information
- Founded
- CTRN 1946
- RCKT 1999
- Country
- CTRN United States
- RCKT United States
- Employees
- CTRN N/A
- RCKT N/A
- Industry
- CTRN Clothing/Shoe/Accessory Stores
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- CTRN Consumer Discretionary
- RCKT Health Care
- Exchange
- CTRN Nasdaq
- RCKT Nasdaq
- Market Cap
- CTRN 281.4M
- RCKT 328.6M
- IPO Year
- CTRN 2005
- RCKT N/A
- Fundamental
- Price
- CTRN $32.94
- RCKT $3.25
- Analyst Decision
- CTRN Buy
- RCKT Buy
- Analyst Count
- CTRN 2
- RCKT 13
- Target Price
- CTRN $31.50
- RCKT $12.96
- AVG Volume (30 Days)
- CTRN 110.8K
- RCKT 5.7M
- Earning Date
- CTRN 08-26-2025
- RCKT 11-06-2025
- Dividend Yield
- CTRN N/A
- RCKT N/A
- EPS Growth
- CTRN N/A
- RCKT N/A
- EPS
- CTRN N/A
- RCKT N/A
- Revenue
- CTRN $782,716,000.00
- RCKT N/A
- Revenue This Year
- CTRN $6.80
- RCKT N/A
- Revenue Next Year
- CTRN $4.61
- RCKT $108.43
- P/E Ratio
- CTRN N/A
- RCKT N/A
- Revenue Growth
- CTRN 3.32
- RCKT N/A
- 52 Week Low
- CTRN $16.18
- RCKT $2.19
- 52 Week High
- CTRN $39.37
- RCKT $22.01
- Technical
- Relative Strength Index (RSI)
- CTRN 45.29
- RCKT 51.65
- Support Level
- CTRN $33.06
- RCKT N/A
- Resistance Level
- CTRN $34.74
- RCKT $3.30
- Average True Range (ATR)
- CTRN 1.95
- RCKT 0.16
- MACD
- CTRN -0.47
- RCKT -0.13
- Stochastic Oscillator
- CTRN 2.58
- RCKT 86.92
About CTRN Citi Trends Inc.
Citi Trends Inc is a retailer of urban fashion apparel and accessories in the United States. The company offers apparel, including fashion sportswear for men and women, as well as children, such as newborns, infants, toddlers, boys, and girls; accessories comprising handbags, jewelry, footwear, belts, intimate apparel, scrubs, and sleepwear; and functional and decorative home products, as well as beauty products, books and toys.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.